Dora Pascual‐Salcedo

5.7k total citations
136 papers, 3.5k citations indexed

About

Dora Pascual‐Salcedo is a scholar working on Rheumatology, Immunology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Dora Pascual‐Salcedo has authored 136 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 82 papers in Rheumatology, 64 papers in Immunology and 32 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Dora Pascual‐Salcedo's work include Rheumatoid Arthritis Research and Therapies (62 papers), Systemic Lupus Erythematosus Research (44 papers) and Monoclonal and Polyclonal Antibodies Research (32 papers). Dora Pascual‐Salcedo is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (62 papers), Systemic Lupus Erythematosus Research (44 papers) and Monoclonal and Polyclonal Antibodies Research (32 papers). Dora Pascual‐Salcedo collaborates with scholars based in Spain, Netherlands and United States. Dora Pascual‐Salcedo's co-authors include Alejandro Balsa, Javier Martı́n, E. Martín‐Mola, Miguel Á. González‐Gay, Miguel Ángel López‐Nevot, Emilio G. de la Concha, Benjamín Fernández‐Gutiérrez, Gisela Orozco, Alfonso Martínez and Laura Nuño and has published in prestigious journals such as Blood, The Journal of Immunology and PLoS ONE.

In The Last Decade

Dora Pascual‐Salcedo

134 papers receiving 3.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dora Pascual‐Salcedo Spain 33 1.6k 1.5k 777 548 540 136 3.5k
Richard Aranda United States 20 1.3k 0.8× 1.3k 0.8× 464 0.6× 630 1.1× 366 0.7× 37 3.2k
Carla A. Wijbrandts Netherlands 30 1.7k 1.1× 1.1k 0.7× 443 0.6× 201 0.4× 619 1.1× 47 2.9k
P. C. Limburg Netherlands 33 1.3k 0.8× 1.3k 0.8× 543 0.7× 227 0.4× 417 0.8× 52 3.6k
Koichiro Ohmura Japan 35 1.8k 1.1× 1.9k 1.3× 872 1.1× 221 0.4× 611 1.1× 170 4.3k
David Hagerty United States 19 1.3k 0.8× 1.6k 1.0× 412 0.5× 284 0.5× 470 0.9× 34 4.2k
Swapan K. Nath United States 32 1.6k 1.0× 1.9k 1.3× 838 1.1× 960 1.8× 506 0.9× 103 3.9k
Serge Steinfeld Belgium 21 1.7k 1.1× 1.3k 0.9× 432 0.6× 294 0.5× 313 0.6× 52 3.4k
Olivier Vittecoq France 36 2.0k 1.2× 776 0.5× 581 0.7× 216 0.4× 462 0.9× 165 3.5k
Margit Zeher Hungary 39 1.6k 1.0× 1.6k 1.1× 653 0.8× 485 0.9× 309 0.6× 147 4.5k
Won Park South Korea 24 1.4k 0.8× 1.9k 1.3× 258 0.3× 419 0.8× 402 0.7× 94 3.2k

Countries citing papers authored by Dora Pascual‐Salcedo

Since Specialization
Citations

This map shows the geographic impact of Dora Pascual‐Salcedo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dora Pascual‐Salcedo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dora Pascual‐Salcedo more than expected).

Fields of papers citing papers by Dora Pascual‐Salcedo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dora Pascual‐Salcedo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dora Pascual‐Salcedo. The network helps show where Dora Pascual‐Salcedo may publish in the future.

Co-authorship network of co-authors of Dora Pascual‐Salcedo

This figure shows the co-authorship network connecting the top 25 collaborators of Dora Pascual‐Salcedo. A scholar is included among the top collaborators of Dora Pascual‐Salcedo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dora Pascual‐Salcedo. Dora Pascual‐Salcedo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Benavent, Diego, Dora Pascual‐Salcedo, Chamaida Plasencia‐Rodríguez, et al.. (2023). Coping with rheumatic stressors (CORS) questionnaire: Spanish translation and cross-cultural adaptation. Journal of Patient-Reported Outcomes. 7(1). 11–11.
2.
Benavent, Diego, Dora Pascual‐Salcedo, Chamaida Plasencia‐Rodríguez, et al.. (2023). Translation and cross-cultural adaptation of the mSQUASH into Spanish. Reumatología Clínica. 19(8). 436–441. 2 indexed citations
3.
Hernández‐Breijo, Borja, Ioannis Parodis, Marta Novella-Navarro, et al.. (2022). Low Serum BAFF Concentration Is Associated with Response to TNF Inhibitors in Seropositive Patients with Rheumatoid Arthritis. Journal of Clinical Medicine. 11(17). 5207–5207. 5 indexed citations
4.
Hernández‐Breijo, Borja, Victoria Navarro‐Compán, Ana Martínez‐Feito, et al.. (2018). FRI0186 Concomitant csdmards influence clinical response to tnf inhibitors only in overweight patients with axial spondyloarthritis. Annals of the Rheumatic Diseases. 77. 634–634. 1 indexed citations
5.
Jurado‐Guerrero, Teresa, Chamaida Plasencia‐Rodríguez, Ana Martínez‐Feito, et al.. (2017). Predictive Value of Serum Infliximab Levels at Induction Phase in Rheumatoid Arthritis Patients. The Open Rheumatology Journal. 11(1). 75–87. 13 indexed citations
6.
Murías, Sara, et al.. (2017). Current Practices for Therapeutic Drug Monitoring of Biopharmaceuticals in Pediatrics. Therapeutic Drug Monitoring. 39(4). 370–378. 6 indexed citations
7.
Moreno-Ramos, Francisco, et al.. (2015). Anti-tnf dose and anti-drug antibody levels in rheumatic and psoriasis patients: Economic repercussion. 17(2). 4. 3 indexed citations
8.
Pascual‐Salcedo, Dora, Sara García, G. Bonilla, et al.. (2013). THU0219 The Infliximab Dose Increase is Not Correlated with Clinical Improvement in RA Patients. Annals of the Rheumatic Diseases. 72. A238–A238. 1 indexed citations
9.
García-Bermúdez, Mercedes, Raquel López‐Mejías, Carlos González‐Juanatey, et al.. (2012). Association Study of MIA3 rs17465637 Polymorphism with Cardiovascular Disease in Rheumatoid Arthritis Patients. DNA and Cell Biology. 31(8). 1412–1417. 13 indexed citations
10.
García-Bermúdez, Mercedes, Raquel López‐Mejías, Carlos González‐Juanatey, et al.. (2012). CARD8 rs2043211 (p.C10X) Polymorphism Is Not Associated with Disease Susceptibility or Cardiovascular Events in Spanish Rheumatoid Arthritis Patients. DNA and Cell Biology. 32(1). 28–33. 28 indexed citations
11.
Plasencia, Chamaida, Dora Pascual‐Salcedo, Laura Nuño, et al.. (2012). Influence of immunogenicity on the efficacy of longterm treatment of spondyloarthritis with infliximab. Annals of the Rheumatic Diseases. 71(12). 1955–1960. 92 indexed citations
12.
Cáliz, Rafael, Alejandro Balsa, Francisco J. Blanco, et al.. (2011). The C677T polymorphism in theMTHFRgene is associated with the toxicity of methotrexate in a Spanish rheumatoid arthritis population. Scandinavian Journal of Rheumatology. 41(1). 10–14. 50 indexed citations
13.
Martín, Jose‐Ezequiel, Behrooz Z. Alizadeh, Miguel Á. González‐Gay, et al.. (2011). Evidence for PTPN22 R620W Polymorphism As the Sole Common Risk Variant for Rheumatoid Arthritis in the 1p13.2 Region. The Journal of Rheumatology. 38(11). 2290–2296. 18 indexed citations
14.
Orozco, Gisela, Dora Pascual‐Salcedo, Miguel Ángel López‐Nevot, et al.. (2007). Auto-antibodies, HLA and PTPN22: susceptibility markers for rheumatoid arthritis. Lara D. Veeken. 47(2). 138–141. 36 indexed citations
15.
Torres, Belén, Gisela Orozco, José R. García‐Lozano, et al.. (2006). Asporin repeat polymorphism in rheumatoid arthritis. Annals of the Rheumatic Diseases. 66(1). 118–120. 22 indexed citations
16.
Miranda‐Carús, María‐Eugenia, Marta Benito, Alejandro Balsa, et al.. (2006). Peripheral blood T lymphocytes from patients with early rheumatoid arthritis express RANKL and interleukin‐15 on the cell surface and promote osteoclastogenesis in autologous monocytes. Arthritis & Rheumatism. 54(4). 1151–1164. 70 indexed citations
17.
Rueda‐Medina, Blanca, Mitsu Reddy, Miguel Á. González‐Gay, et al.. (2006). Analysis of IRF5 gene functional polymorphisms in rheumatoid arthritis. Arthritis & Rheumatism. 54(12). 3815–3819. 44 indexed citations
18.
Detková, Drahomíra, et al.. (1999). Do antibodies to β2-glycoprotein 1 contribute to the better characterization of the antiphospholipid syndrome?. Lupus. 8(6). 430–438. 32 indexed citations
19.
Subiza, José Luis, et al.. (1989). DNA–ANTI‐DNA Complexes account for part of the antihistone activity found in patients with systemic lupus erythematosus. Arthritis & Rheumatism. 32(4). 406–412. 31 indexed citations
20.
Fontán, G, et al.. (1983). Transient hypogammaglobulinemia in the adult. Functional assessment of T and B lymphocytes.. PubMed. 11(1). 55–8. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Richard Aranda Breakdown of academic impact, for papers by Carla A. Wijbrandts Breakdown of academic impact, for papers by P. C. Limburg Breakdown of academic impact, for papers by Koichiro Ohmura Breakdown of academic impact, for papers by David Hagerty Breakdown of academic impact, for papers by Swapan K. Nath Breakdown of academic impact, for papers by Serge Steinfeld Breakdown of academic impact, for papers by Olivier Vittecoq Breakdown of academic impact, for papers by Margit Zeher Breakdown of academic impact, for papers by Won Park
Rankless by CCL
2026